Combination of Fixed Low-Dose Nivolumab and Bendamustine in Children with High-Risk Relapsed/refractory Classical Hodgkin Lymphoma.
British journal of haematology(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined